Katayama I - Search Results

1

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.

Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, Arimitsu J, Narazaki M, Hagihara K, Ogata A, Katayama I, Kawase I, Kishimoto T, Tanaka T. Shima Y, et al. Among authors: katayama i. Rheumatology (Oxford). 2010 Dec;49(12):2408-12. doi: 10.1093/rheumatology/keq275. Epub 2010 Sep 5. Rheumatology (Oxford). 2010. PMID: 20819796 Free PMC article.

2

Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab.

Ogata A, Umegaki N, Katayama I, Kumanogoh A, Tanaka T. Ogata A, et al. Among authors: katayama i. Joint Bone Spine. 2012 Jan;79(1):85-7. doi: 10.1016/j.jbspin.2011.06.011. Epub 2011 Oct 1. Joint Bone Spine. 2012. PMID: 21962389

3

New aspect of anti-inflammatory action of lipo-prostaglandinE1 in the management of collagen diseases-related skin ulcer.

Murota H, Kotobuki Y, Umegaki N, Tani M, Katayama I. Murota H, et al. Among authors: katayama i. Rheumatol Int. 2008 Sep;28(11):1127-35. doi: 10.1007/s00296-008-0589-5. Epub 2008 May 7. Rheumatol Int. 2008. PMID: 18461292

4

Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.

Murota H, Katayama I. Murota H, et al. Among authors: katayama i. Expert Opin Pharmacother. 2009 Aug;10(11):1859-67. doi: 10.1517/14656560903078410. Expert Opin Pharmacother. 2009. PMID: 19558341 Review.

5

Tumor necrosis factor-alpha processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma.

Terao M, Murota H, Kitaba S, Katayama I. Terao M, et al. Among authors: katayama i. Exp Dermatol. 2010 Jan;19(1):38-43. doi: 10.1111/j.1600-0625.2009.00973.x. Epub 2009 Sep 16. Exp Dermatol. 2010. PMID: 19758314

6

A case of disseminated DLE complicated by atopic dermatitis and Sjögren's syndrome: link between hypohidrosis and skin manifestations.

Matsui S, Kitaba S, Itoi S, Kijima A, Murota H, Tani M, Katayama I. Matsui S, et al. Among authors: katayama i. Mod Rheumatol. 2011 Feb;21(1):101-5. doi: 10.1007/s10165-010-0352-0. Epub 2010 Sep 8. Mod Rheumatol. 2011. PMID: 20824298

7

Assessment of antihistamines in the treatment of skin allergies.

Murota H, Katayama I. Murota H, et al. Among authors: katayama i. Curr Opin Allergy Clin Immunol. 2011 Oct;11(5):428-37. doi: 10.1097/ACI.0b013e32834a96e9. Curr Opin Allergy Clin Immunol. 2011. PMID: 21841471 Review.

8

Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma.

Kitaba S, Murota H, Terao M, Azukizawa H, Terabe F, Shima Y, Fujimoto M, Tanaka T, Naka T, Kishimoto T, Katayama I. Kitaba S, et al. Among authors: katayama i. Am J Pathol. 2012 Jan;180(1):165-76. doi: 10.1016/j.ajpath.2011.09.013. Epub 2011 Nov 7. Am J Pathol. 2012. PMID: 22062222 Free article.

9

Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma.

Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, Kitaba S, Matsui S, Kudo A, Naka T, Murota H, Katayama I. Yang L, et al. Among authors: katayama i. PLoS One. 2012;7(7):e41994. doi: 10.1371/journal.pone.0041994. Epub 2012 Jul 24. PLoS One. 2012. PMID: 22911870 Free PMC article.

10

Systemic sclerosis with sarcoidosis: case report and review of the published work.

Senda S, Igawa K, Nishioka M, Murota H, Katayama I. Senda S, et al. Among authors: katayama i. J Dermatol. 2014 May;41(5):421-3. doi: 10.1111/1346-8138.12438. Epub 2014 Mar 12. J Dermatol. 2014. PMID: 24617417 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

856 results

Search Page

Filters